These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 19012907)

  • 1. Effectiveness of antibiotics given to asymptomatic men for an increased prostate specific antigen.
    Baltaci S; Süer E; Haliloğlu AH; Gokce MI; Elhan AH; Bedük Y
    J Urol; 2009 Jan; 181(1):128-32. PubMed ID: 19012907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Percent free prostate specific antigen does not enhance the specificity of total prostate specific antigen for the detection of prostate cancer in Korean men 50 to 65 years old: a prospective multicenter study.
    Jeong IG; Lee KH;
    J Urol; 2008 Jan; 179(1):111-6. PubMed ID: 17997422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Percent free prostate-specific antigen (PSA) is an accurate predictor of prostate cancer risk in men with serum PSA 2.5 ng/mL and lower.
    Walz J; Haese A; Scattoni V; Steuber T; Chun FK; Briganti A; Montorsi F; Graefen M; Huland H; Karakiewicz PI
    Cancer; 2008 Nov; 113(10):2695-703. PubMed ID: 18853417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibiotics and observation have a similar impact on asymptomatic patients with a raised PSA.
    Heldwein FL; Teloken PE; Hartmann AA; Rhoden EL; Teloken C
    BJU Int; 2011 May; 107(10):1576-81. PubMed ID: 21244610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of antibacterial therapy on PSA change in the presence and absence of prostatic inflammation in patients with PSA levels between 4 and 10 ng/ml.
    Kaygisiz O; Uğurlu O; Koşan M; Inal G; Oztürk B; Cetinkaya M
    Prostate Cancer Prostatic Dis; 2006; 9(3):235-8. PubMed ID: 16718277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do changes in a high serum prostate-specific antigen level and the free/total prostate-specific antigen ratio after antibiotic treatment rule out biopsy and the suspicion of cancer?
    Dirim A; Tekin MI; Koyluoglu E; Oguzulgen AI; Peskircioglu L; Ozkardes H
    Urol Int; 2009; 82(3):266-9. PubMed ID: 19440011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum PSA and percent free PSA value changes after antibiotic treatment. A diagnostic method in prostate cancer suspects with asymptomatic prostatitis.
    Kobayashi M; Nukui A; Morita T
    Urol Int; 2008; 80(2):186-92. PubMed ID: 18362491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostate specific antigen decrease and prostate cancer diagnosis: antibiotic versus placebo prospective randomized clinical trial.
    Stopiglia RM; Ferreira U; Silva MM; Matheus WE; Denardi F; Reis LO
    J Urol; 2010 Mar; 183(3):940-4. PubMed ID: 20089269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostate specific antigen velocity in men with total prostate specific antigen less than 4 ng/ml.
    Loeb S; Roehl KA; Nadler RB; Yu X; Catalona WJ
    J Urol; 2007 Dec; 178(6):2348-52; discussion 2352-3. PubMed ID: 17936844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of prostate cancer at different levels of serum prostate-specific antigen (PSA) and different free: total PSA ratios in a consecutive series of men referred for prostate biopsies.
    Rydén L; Egevad L; Ekman P; Hellström M
    Scand J Urol Nephrol; 2007; 41(4):302-7. PubMed ID: 17763221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Value of prostate-specific antigen and prostate-specific antigen density in detection of prostate cancer in an Iranian population of men.
    Ghafoori M; Varedi P; Hosseini SJ; Asgari M; Shakiba M
    Urol J; 2009; 6(3):182-8. PubMed ID: 19711272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of prostate cancer for young men with a prostate specific antigen less than their age specific median.
    Loeb S; Nadler RB; Roehl KA; Antenor JA; Catalona WJ
    J Urol; 2007 May; 177(5):1745-8. PubMed ID: 17437803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential of magnetic resonance spectroscopic imaging in predicting absence of prostate cancer in men with serum prostate-specific antigen between 4 and 10 ng/ml: a follow-up study.
    Kumar R; Nayyar R; Kumar V; Gupta NP; Hemal AK; Jagannathan NR; Dattagupta S; Thulkar S
    Urology; 2008 Oct; 72(4):859-63. PubMed ID: 18329078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of 6- and 12-core prostate biopsy in Taiwanese men: impact of total prostate-specific antigen, prostate-specific antigen density and prostate volume on prostate cancer detection.
    Chiang IN; Chang SJ; Pu YS; Huang KH; Yu HJ; Huang CY
    Urol Int; 2009; 82(3):270-5. PubMed ID: 19440012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Change in prostate specific antigen following androgen stimulation is an independent predictor of prostate cancer diagnosis.
    Svatek RS; Shulman MJ; Benaim EA; Rogers TE; Margulis V
    J Urol; 2008 Jun; 179(6):2192-5; discussion 2195-6. PubMed ID: 18423746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of prostate cancer among hypogonadal men with prostate-specific antigen levels of 4.0 ng/mL or less.
    Morgentaler A; Rhoden EL
    Urology; 2006 Dec; 68(6):1263-7. PubMed ID: 17169647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of chronic prostatitis lowers serum prostate specific antigen.
    Bozeman CB; Carver BS; Eastham JA; Venable DD
    J Urol; 2002 Apr; 167(4):1723-6. PubMed ID: 11912396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The association between total prostate specific antigen concentration and prostate specific antigen velocity.
    Yu X; Loeb S; Roehl KA; Han M; Catalona WJ
    J Urol; 2007 Apr; 177(4):1298-302; discussion 1301-2. PubMed ID: 17382716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of obesity on the diagnosis of prostate cancer using a modern extended biopsy scheme.
    Pruthi RS; Swords K; Schultz H; Carson CC; Wallen EM
    J Urol; 2009 Feb; 181(2):574-7; discussion 578. PubMed ID: 19084847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of percent free PSA for prostate cancer detection in men with a total PSA of 4-10 ng/ml.
    Bermúdez-Tamayo C; Martín Martín JJ; González Mdel P; Pérez Romero C
    Urol Int; 2007; 79(4):336-44. PubMed ID: 18025853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.